Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: MBIA Inc. (NYSE:MBI), Hovnanian Enterprises, Inc. (NYSE:HOV), Molycorp Inc (NYSE:MCP), MannKind Corporation (NASDAQ:MNKD)
MBIA Inc. (NYSE:MBI) managed to keep fall at -1.45% on above-normal volume of 4.55M shares. The stock settled at $10.23 after floating in a range of $10.16 to $10.46. Its latest price has reached market capitalization of $1.97 billion. Its 52-week range has been $6.78 to $16.75. MBIA Inc., together with its subsidiaries, provides financial guarantee insurance and related reinsurance, advisory, and portfolio services for the public and structured finance markets; and asset management advisory services in the United States and internationally.
Has MBI Found The Bottom and Ready To Move Up? Find Out Here
Hovnanian Enterprises, Inc. (NYSE:HOV) traded up on a volume of 4.38 million, lower than its standard daily volume. Shares have gained 1.36% to $5.23. Over the last twelve months, the stock has gained 51.16% and faced a worst price of $3.27. Hovnanian Enterprises Inc. designs, constructs, markets, and sells residential homes in the United States. It builds garden homes, townhomes, single family homes, mid and high rise luxury homes, estate homes, adult lifestyle communities, attached and detached homes, urban infill locations, and townhomes and condominiums.
For How Long HOV’s Gloss will Attract Investors? Find out via this report
Molycorp Inc (NYSE:MCP) settled -2.53% lower at $6.56 on below -normal volume of 4.17M shares during the last trading day. The stock has its 12-month high at $11.89 and 52-week low price was $4.70. It traded in a range of $6.51 to $6.72 during the last trading day. Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally.
Will MCP Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, MannKind Corporation (NASDAQ:MNKD) was down on low volume, trading at a volume of 4.01 M versus its average daily volume of 6.81 million shares. At $5.70, the stock has attained market capitalization of 1.72 billion. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Why Should Investors Buy MNKD After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)